<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药魔方 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-06T17:34:08+08:00</updated>
  <subtitle>世事洞明皆学问，人情练达即文章</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>深耕中国市场26载！罗氏携6款创新药产品闪耀进博舞台</title>
    <updated>2020-11-06T16:28:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/J94LL9IEKkyuTcLkhYbw7A</id>
    <link href="https://mp.weixin.qq.com/s/J94LL9IEKkyuTcLkhYbw7A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>临床研究月报 | 2020年10月</title>
    <updated>2020-11-06T16:28:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/l1RsbPajQe-i8smwPxpfHw</id>
    <link href="https://mp.weixin.qq.com/s/l1RsbPajQe-i8smwPxpfHw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药魔方招聘：数据分析师（疫苗方向）</title>
    <updated>2020-11-06T16:28:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/G6gf31IRfcACLoFIMY5-qA</id>
    <link href="https://mp.weixin.qq.com/s/G6gf31IRfcACLoFIMY5-qA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>实体肿瘤新突破！Selinexor用于脂肪肉瘤III期临床研究达到主要终点</title>
    <updated>2020-11-06T16:28:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/klyWipUV0ws6kDmUg_hZkg</id>
    <link href="https://mp.weixin.qq.com/s/klyWipUV0ws6kDmUg_hZkg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>愈磐生物创始人钱锋/寇翔：刹那抉择，不过是有意无意的经年积累</title>
    <updated>2020-11-05T07:41:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/zXvKjs-NNP2NTph9syN0pA</id>
    <link href="https://mp.weixin.qq.com/s/zXvKjs-NNP2NTph9syN0pA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>总资助3.28亿美元！CEPI与三叶草生物扩大合作，推进S-三聚体新冠疫苗临床开发及上市</title>
    <updated>2020-11-04T07:52:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/BkULmtxzsmJVErRzeq759Q</id>
    <link href="https://mp.weixin.qq.com/s/BkULmtxzsmJVErRzeq759Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>先声药业管线中这个小分子，为何被FDA认定为突破性疗法？</title>
    <updated>2020-11-04T07:52:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/NG6W8aV95yQMDMKefNv0dQ</id>
    <link href="https://mp.weixin.qq.com/s/NG6W8aV95yQMDMKefNv0dQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药魔方招聘： HEOR Senior Manager, Associate Director, Director</title>
    <updated>2020-11-04T07:52:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/ilX2wiboAVUFkndGkb8EMQ</id>
    <link href="https://mp.weixin.qq.com/s/ilX2wiboAVUFkndGkb8EMQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>今年第10家！药明巨诺正式在港交所挂牌上市</title>
    <updated>2020-11-03T08:05:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/PnUR8zteMx7cp4v8G9M1ug</id>
    <link href="https://mp.weixin.qq.com/s/PnUR8zteMx7cp4v8G9M1ug" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>攻关难治性肿瘤、精苛生物工艺，这一医药“黑马”能否缔造新神话？</title>
    <updated>2020-11-03T08:05:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/UieH5YaK4Cv0hWcUX67DKg</id>
    <link href="https://mp.weixin.qq.com/s/UieH5YaK4Cv0hWcUX67DKg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>风云雄霸天下，晚期胃癌一线免疫治疗谁与争锋？</title>
    <updated>2020-11-03T08:05:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/lMVgKb-88lC63cVLgasjqQ</id>
    <link href="https://mp.weixin.qq.com/s/lMVgKb-88lC63cVLgasjqQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Biotech的新十年</title>
    <updated>2020-11-02T08:01:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/0m1wsras6KQgi6i1RdhmnA</id>
    <link href="https://mp.weixin.qq.com/s/0m1wsras6KQgi6i1RdhmnA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>康方生物PD-1/VEGF双抗Ia期研究初步数据喜人：对PD-1不敏感型实体瘤患者效果良好</title>
    <updated>2020-11-02T08:01:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/qOloSi5V93uNJUunMtyw0A</id>
    <link href="https://mp.weixin.qq.com/s/qOloSi5V93uNJUunMtyw0A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>紫苑生物与捷思英达达成许可协议，引进AT-0287非肿瘤适应症全球开发权益</title>
    <updated>2020-11-02T08:01:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/r0vqVwMjKz6RxcHDiuPNyw</id>
    <link href="https://mp.weixin.qq.com/s/r0vqVwMjKz6RxcHDiuPNyw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>远大医药不超过2.5亿美元引进Telix公司6款放射性核素偶联药物</title>
    <updated>2020-11-02T08:01:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/YO94gNRDCEEK2z425sZGDQ</id>
    <link href="https://mp.weixin.qq.com/s/YO94gNRDCEEK2z425sZGDQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Astellas放弃开发TIGIT单抗</title>
    <updated>2020-10-31T19:47:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-31:/s/-o382HH4yv9O8-emjdhCnA</id>
    <link href="https://mp.weixin.qq.com/s/-o382HH4yv9O8-emjdhCnA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药魔方招聘：医学经理</title>
    <updated>2020-10-31T19:47:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-31:/s/diII7OX6sEOT2iLRexNrmg</id>
    <link href="https://mp.weixin.qq.com/s/diII7OX6sEOT2iLRexNrmg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药魔方招聘：医学数据经理</title>
    <updated>2020-10-31T19:47:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-31:/s/ZA1BMbU4HCUqdjmtxYe_Mw</id>
    <link href="https://mp.weixin.qq.com/s/ZA1BMbU4HCUqdjmtxYe_Mw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药魔方招聘：助理产品经理（医药大数据）</title>
    <updated>2020-10-31T19:47:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-31:/s/0k3bpdpo9K4Pj7HoGpH_WA</id>
    <link href="https://mp.weixin.qq.com/s/0k3bpdpo9K4Pj7HoGpH_WA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>基因疗法赛道持续升温：巨资入场，未来可期</title>
    <updated>2020-10-30T07:44:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-30:/s/lt1V8EjKaAqeI90IivQjxA</id>
    <link href="https://mp.weixin.qq.com/s/lt1V8EjKaAqeI90IivQjxA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>